September 25, 2017 08:59 AM EDTUpdated 12:24 PM

Spark recruits gene therapy expert Mingozzi as new CSO; Fusion brings venture round to $46M; China OKs Gilead’s Sovaldi for hep C

Shehla Shakoor

Managing Director

⇨ Spark Therapeutics $ONCE has recruited Federico Mingozzi, a noted gene therapy expert at INSERM and Genethon in France, as chief scientific officer. Mingozzi …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Spark recruits gene therapy expert Mingozzi as new CSO; Fusion brings venture round to $46M; China OKs Gilead’s Sovaldi for hep C

Shehla Shakoor

Managing Director

Sign up to read this article for free.

Trump names Johns Hopkins researcher Marty Makary to lead the FDA; also names CDC, Surgeon General picks

FDA approves BridgeBio's heart disease drug, setting up competition with Pfizer, Alnylam

Drug or biologic? An Eli Lilly lawsuit could impact weight loss drug compounders

Patient dies in Neurogene's Rett syndrome study

Lilly's board undergoes more changes; Merck strategy chief joins Roger Perlmutter at Eikon

Are programs with compounded GLP-1s safe for your population?

Spark re­cruits gene ther­a­py ex­pert Min­gozzi as new CSO; Fu­sion brings ven­ture round to $46M; Chi­na OKs Gilead’s So­val­di for hep C

Shehla Shakoor

Managing Director

Sign up to read this article for free.

Trump names Johns Hop­kins re­searcher Mar­ty Makary to lead the FDA; al­so names CDC, Sur­geon Gen­er­al picks

FDA ap­proves Bridge­Bio's heart dis­ease drug, set­ting up com­pe­ti­tion with Pfiz­er, Al­ny­lam

Drug or bi­o­log­ic? An Eli Lil­ly law­suit could im­pact weight loss drug com­pounders

Pa­tient dies in Neu­ro­gene's Rett syn­drome study

Lil­ly's board un­der­goes more changes; Mer­ck strat­e­gy chief joins Roger Perl­mut­ter at Eikon

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

Spark recruits gene therapy expert Mingozzi as new CSO; Fusion brings venture round to $46M; China OKs Gilead’s Sovaldi for hep C

Trump names Johns Hopkins researcher Marty Makary to lead the FDA; also names CDC, Surgeon General picks

FDA approves BridgeBio's heart disease drug, setting up competition with Pfizer, Alnylam

Drug or biologic? An Eli Lilly lawsuit could impact weight loss drug compounders

Patient dies in Neurogene's Rett syndrome study

Lilly's board undergoes more changes; Merck strategy chief joins Roger Perlmutter at Eikon

Are programs with compounded GLP-1s safe for your population?